EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico

Paulina M Mejía-Ponce, Elsy J Ramos-González, Axel A Ramos-García, Edgar E Lara-Ramírez, Alma R Soriano-Herrera, Mitzy F Medellín-Luna, Fernando Valdez-Salazar iD, Claudia Y Castro-Garay, José J Núñez-Contreras, Marcos De Donato-Capote iD, Ashutosh Sharma, Julio E Castañeda-Delgado und 3 weitere

PLOS ONE · 13.10.2023 · 18 (10) · e0292965

DOI: 10.1371/journal.pone.0292965 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 13.10.2023. Verfasst von Paulina M Mejía-Ponce und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Nuevo León, México. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant, Tuberculosis. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Consejo Nacional de Ciencia y Tecnología, Centro de Biotecnologia FEMSA, Tecnologico de Monterrey.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genomics has significantly revolutionized pathogen surveillance, particularly in epidemiological studies, the detection of drug-resistant strains, and disease control. Despite its potential, the representation of Latin American countries in the genomic catalogues of Mycobacterium tuberculosis (Mtb) , the bacteria responsible for Tuberculosis (TB), remains limited. In this study, we present a whole genome sequencing (WGS)-based analysis of 85 Mtb clinical strains from 17 Mexican states, providing insights into local adaptations and drug resistance signatures in the region. Our results reveal that the Euro-American lineage (L4) accounts for 94% of our dataset, showing 4.1.2.1 (Haarlem, n = 32), and 4.1.1.3 (X-type, n = 34) sublineages as the most prevalent. We report the presence of the 4.1.1.3 sublineage, which is endemic to Mexico, in six additional locations beyond previous reports. Phenotypic drug resistance tests showed that 34 out of 85 Mtb samples were resistant, exhibiting a variety of resistance profiles to the first-line antibiotics tested. We observed high levels of discrepancy between phenotype and genotype associated with drug resistance in our dataset, including pyrazinamide-monoresistant Mtb strains lacking canonical variants of drug resistance. Expanding the Latin American Mtb genome databases will enhance our understanding of TB epidemiology and potentially provide new avenues for controlling the disease in the region.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantTuberculosisHumansAntitubercular AgentsMexicoGenotypeGenomicsMicrobial Sensitivity TestsDrug Resistance, Multiple, Bacterial

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Centro de Biotecnología FEMSA, Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Nuevo León, México.
  • Unidad de Investigación Biomédica de Zacatecas, Instituto Mexicano Del Seguro Social, Zacatecas, México.
  • Posgrado en Ciencias Farmacobiológicas, Universidad Autónoma de San Luis Potosí, San Luis Potosí, México.
  • Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Querétaro, México.
  • Consejo Nacional de Ciencia y Tecnología, CONACYT, Ciudad de México, México.
  • Instituto de Salud Pública, Universidad Veracruzana, Veracruz, México.

ORCID-Profile: Fernando Valdez-Salazar, Marcos De Donato-Capote, Cuauhtémoc Licona-Cassani

Förderung

  • Consejo Nacional de Ciencia y Tecnología
  • Centro de Biotecnologia FEMSA, Tecnologico de Monterrey

Zitieren

APA

Mejía-Ponce, P. M., Ramos-González, E. J., Ramos-García, A. A., Lara-Ramírez, E. E., Soriano-Herrera, A. R., Medellín-Luna, M. F., Valdez-Salazar, F., Castro-Garay, C. Y., Núñez-Contreras, J. J., De Donato-Capote, M., Sharma, A., Castañeda-Delgado, J. E., Zenteno-Cuevas, R., Enciso-Moreno, J. A., & Licona-Cassani, C. (2023). Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico. PLOS ONE, 18(10), e0292965. https://doi.org/10.1371/journal.pone.0292965

Vancouver

Mejía-Ponce PM, Ramos-González EJ, Ramos-García AA, Lara-Ramírez EE, Soriano-Herrera AR, Medellín-Luna MF, et al. Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico. PLOS ONE. 2023;18(10):e0292965. doi:10.1371/journal.pone.0292965

BibTeX
@article{MejaPonce2023,
  author = {Mejía-Ponce, Paulina M and Ramos-González, Elsy J and Ramos-García, Axel A and Lara-Ramírez, Edgar E and Soriano-Herrera, Alma R and Medellín-Luna, Mitzy F and Valdez-Salazar, Fernando and Castro-Garay, Claudia Y and Núñez-Contreras, José J and De Donato-Capote, Marcos and Sharma, Ashutosh and Castañeda-Delgado, Julio E and Zenteno-Cuevas, Roberto and Enciso-Moreno, Jose Antonio and Licona-Cassani, Cuauhtémoc},
  title = {Genomic epidemiology analysis of drug-resistant Mycobacterium tuberculosis distributed in Mexico},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {10},
  pages = {e0292965},
  doi = {10.1371/journal.pone.0292965}
}
Kostenlos starten →